Patent · US Active

Methods of treating neurofibromatosis with perillyl alcohol

US11147809B2 · kind B2 · utility

2Cited by
0References
28Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 30, 2017
Grant dateOct 19, 2021
Priority date
Expiry dateJun 30, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present methods treat neurofibromatosis by a administering to a subject perillyl alcohol or iso-perillyl alcohol. The present methods also treat neurofibromatosis by administering to a subject a carbamate of perillyl alcohol, or a carbamate of iso-perillyl alcohol. The perillyl alcohol carbamate may comprise perillyl alcohol conjugated with rolipram or temozolomide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.